An unconventional but effective treatment against a deadly superbug is raising worries about a possible black market.» Read More
Alarm bells over the lack of high tech workers in the U.S. have been ringing for years. Most analysts say the problem is worse, but some say it's overblown.
Faced with more service members returning without limbs from Iraq and Afghanistan, scientists, the government and private-sector companies are using new materials, tools and techniques to create sophisticated prostheses for amputees.
If you're worried about how yours might fare during a downturn, consider a recession-proof industry, which caters to ongoing demands.
Looking ahead to 2050, Carl McDonald, Citi health care analyst, shares insight on how cost could change, which companies will benefit, and ways in which Medicare and Medicaid could develop.
The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.
Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.
Physicians are embracing Web-based software solutions that are bringing healthcare services into the home.
Insight on treating epilepsy, with Daniel Moore, Cyberonics president & CEO.
A spokesman for the medical-technology industry warned that a new medical-device tax that goes into effect in 2013 under the Obama health-care law could force some companies to cut jobs.
Insight on how the difficult time in the U.S. is impacting the business of medical technology, with José Almeida, Covidien president/CEO.
Athenahealth, a cloud-based physician software vendor, has continued to hit new highs this year with the stock up 48% year-to-date and 33% revenue growth since last year. Jonathan Bush, Athenahealth CEO, discusses what's behind the company's success.
Here is our list of the 15 of the most influential inventions over the past 50 years, created using a variety of studies as reference points, including ones from Knowledge@Wharton and Popular Mechanics.
Though the U.S. had made much progress taking medical record keeping into the digital age, there's still some doubt that the government will reach its target by the prescribed deadline.
The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers. The New York Times reports.
Blood-testing equipment maker Immucor says it agreed to be acquired by TPG Capital in a deal worth $1.97 billion, or $27 per share in cash.
Ranking No. 1 for the 5th year running, California surpassed even its own 2010 performance. Yet, tech-savvy runners-up to the Silicon Valley state aren’t that far behind.
Biotech is projected to expand at an annual rate of 1.5%. A look at innovation and growth in the industry, with Jim Greenwood, Biotechnology Industry Organization president/CEO.
Making a case for lap-band surgery and discussing the benefits to patients and insurance companies, with David Pyott, Allergan CEO.
A new test developed by a unit of biotech company Life Technologies has shown success in quickly pinpointing the strain of E. coli involved in a European outbreak that has killed 25 people and sickened more than 2,400 worldwide.
While growing computing demand will mean more energy consumption, wider use of cloud computing technology will prove to be a net benefit to the environment over the longer term, say industry watchers.